Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 462

1.

Characterizing high-grade serous papillary carcinoma of tunica vaginalis.

Qu LG, Teh J, Mitchell C, Gyorki DE, Hicks RJ, Murphy DG.

Urol Case Rep. 2019 Jun 21;26:100949. doi: 10.1016/j.eucr.2019.100949. eCollection 2019 Sep.

2.

Are we ready to adopt the European Association of Urology recommendations on multiparametric magnetic resonance imaging in the early detection of prostate cancer?

Thangasamy IA, Alghazo O, Murphy DG.

Investig Clin Urol. 2019 Jul;60(4):225-226. doi: 10.4111/icu.2019.60.4.225. Epub 2019 May 29. No abstract available.

3.

Detection and localisation of primary prostate cancer using 68 Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens.

Kalapara AA, Nzenza T, Pan HY, Ballok Z, Ramdave S, O'Sullivan R, Ryan A, Cherk M, Hofman MS, Konety BR, Lawrentschuk N, Bolton D, Murphy DG, Grummet JP, Frydenberg M.

BJU Int. 2019 Jul 1. doi: 10.1111/bju.14858. [Epub ahead of print]

PMID:
31260602
4.

The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD).

Pretzsch CM, Voinescu B, Mendez MA, Wichers R, Ajram L, Ivin G, Heasman M, Williams S, Murphy DG, Daly E, McAlonan GM.

J Psychopharmacol. 2019 Jun 25:269881119858306. doi: 10.1177/0269881119858306. [Epub ahead of print]

PMID:
31237191
5.

Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.

Porter LH, Lawrence MG, Wang H, Clark AK, Bakshi A, Obinata D, Goode D, Papargiris M, Mural, Clouston D, Ryan A, Norden S, Corey E, Nelson PS, Isaacs JT, Grummet J, Kourambas J, Sandhu S, Murphy DG, Pook D, Frydenberg M, Taylor RA, Risbridger GP.

Prostate. 2019 Aug;79(11):1326-1337. doi: 10.1002/pros.23839. Epub 2019 Jun 18.

PMID:
31212368
6.

The role of 18F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!

Hung TJ, McLean L, Mitchell C, Pascoe C, Lawrentschuk N, Murphy DG, Iravani A, Singh D, Hofman MS, Zidan L, Akhurst T, Lewin J, Hicks RJ.

Cancer Imaging. 2019 May 29;19(1):28. doi: 10.1186/s40644-019-0217-5.

7.

Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team.

Murphy DG, Hofman MS, Azad A, Violet J, Hicks RJ, Lawrentschuk N.

BJU Int. 2019 May 24. doi: 10.1111/bju.14814. [Epub ahead of print] No abstract available.

PMID:
31127664
8.

Re: Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer.

Alghazo O, Thangasamy I, Sathianathen N, Murphy DG.

Eur Urol. 2019 May 14. pii: S0302-2838(19)30342-2. doi: 10.1016/j.eururo.2019.04.028. [Epub ahead of print] No abstract available.

PMID:
31101535
9.

Salvage Radical Prostatectomy of Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.

Gontero P, Marra G, Alessio P, Filippini C, Oderda M, Munoz F, Linares E, Sanchez-Salas R, Challacombe B, Dasgupta P, Goonewardene S, Popert R, Cahill D, Gillatt D, Persad R, Palou J, Joniau S, Piechaud T, Morlacco A, Vidit S, Rouprêt M, De La Taille A, Albisinni S, Gandaglia G, Mottrie A, Joshi S, Fiscus G, Berger A, Aron M, Van Der Poel H, Tilki D, Lawrentschuk N, Murphy DG, Leung G, Davis J, Karnes RJ; Collaborators.

J Urol. 2019 May 10:101097JU0000000000000327. doi: 10.1097/JU.0000000000000327. [Epub ahead of print]

PMID:
31075058
10.

Large-scale analyses of the relationship between sex, age and intelligence quotient heterogeneity and cortical morphometry in autism spectrum disorder.

Bedford SA, Park MTM, Devenyi GA, Tullo S, Germann J, Patel R, Anagnostou E, Baron-Cohen S, Bullmore ET, Chura LR, Craig MC, Ecker C, Floris DL, Holt RJ, Lenroot R, Lerch JP, Lombardo MV, Murphy DGM, Raznahan A, Ruigrok ANV, Smith E, Spencer MD, Suckling J, Taylor MJ, Thurm A; MRC AIMS Consortium, Lai MC, Chakravarty MM.

Mol Psychiatry. 2019 Apr 26. doi: 10.1038/s41380-019-0420-6. [Epub ahead of print]

PMID:
31028290
11.

Where to Next for Theranostics in Prostate Cancer?

Murphy DG, Sathianathen N, Hofman MS, Azad A, Lawrentschuk N.

Eur Urol Oncol. 2019 Mar;2(2):163-165. doi: 10.1016/j.euo.2019.03.004. Epub 2019 Mar 29. No abstract available.

PMID:
31017092
12.

Adverse impact of malnutrition markers on major abdominopelvic cancer surgery.

Sathianathen NJ, Kwaan M, Lawrentschuk N, Weight CJ, Kim SP, Murphy DG, Moon DA, Konety BR.

ANZ J Surg. 2019 May;89(5):509-514. doi: 10.1111/ans.15129. Epub 2019 Apr 8.

PMID:
30959573
13.

Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Teh J, Narasimhan V, Schultz S, Sathianathen N, Murphy DG.

Eur Urol. 2019 Jul;76(1):126-127. doi: 10.1016/j.eururo.2019.03.002. Epub 2019 Mar 14. No abstract available.

PMID:
30879791
14.

Adding Colour to the Grey Zone of Advanced Prostate Cancer.

Murphy DG, Padhani AR, Ost P.

Eur Urol Focus. 2019 Mar;5(2):123-124. doi: 10.1016/j.euf.2019.02.015. Epub 2019 Feb 26.

PMID:
30824379
15.

The influence of BRCA2 mutation on localized prostate cancer.

Taylor RA, Fraser M, Rebello RJ, Boutros PC, Murphy DG, Bristow RG, Risbridger GP.

Nat Rev Urol. 2019 May;16(5):281-290. doi: 10.1038/s41585-019-0164-8. Review.

PMID:
30808988
16.

Familial risk of autism alters subcortical and cerebellar brain anatomy in infants and predicts the emergence of repetitive behaviors in early childhood.

Pote I, Wang S, Sethna V, Blasi A, Daly E, Kuklisova-Murgasova M, Lloyd-Fox S, Mercure E, Busuulwa P, Stoencheva V, Charman T, Williams SCR, Johnson MH, Murphy DGM, McAlonan GM; BASIS Team.

Autism Res. 2019 Apr;12(4):614-627. doi: 10.1002/aur.2083. Epub 2019 Feb 22.

17.

Strategies for Evaluation of Novel Imaging in Prostate Cancer: Putting the Horse Back Before the Cart.

Vapiwala N, Hofman MS, Murphy DG, Williams S, Sweeney C.

J Clin Oncol. 2019 Apr 1;37(10):765-769. doi: 10.1200/JCO.18.01927. Epub 2019 Feb 22. No abstract available.

PMID:
30794477
18.

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, Christidis D, Bolton D, Hofman MS, Lawrentschuk N, Murphy DG.

Eur Urol. 2019 Feb 14. pii: S0302-2838(19)30095-8. doi: 10.1016/j.eururo.2019.01.049. [Epub ahead of print] Review.

PMID:
30773328
19.

Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.

Pretzsch CM, Freyberg J, Voinescu B, Lythgoe D, Horder J, Mendez MA, Wichers R, Ajram L, Ivin G, Heasman M, Edden RAE, Williams S, Murphy DGM, Daly E, McAlonan GM.

Neuropsychopharmacology. 2019 Jul;44(8):1398-1405. doi: 10.1038/s41386-019-0333-8. Epub 2019 Feb 6.

PMID:
30758329
20.

Investigating the factors underlying adaptive functioning in autism in the EU-AIMS Longitudinal European Autism Project.

Tillmann J, San José Cáceres A, Chatham CH, Crawley D, Holt R, Oakley B, Banaschewski T, Baron-Cohen S, Bölte S, Buitelaar JK, Durston S, Ham L, Loth E, Simonoff E, Spooren W, Murphy DG, Charman T; EU-AIMS LEAP group.

Autism Res. 2019 Apr;12(4):645-657. doi: 10.1002/aur.2081. Epub 2019 Feb 11.

21.

Altered Connectivity Between Cerebellum, Visual, and Sensory-Motor Networks in Autism Spectrum Disorder: Results from the EU-AIMS Longitudinal European Autism Project.

Oldehinkel M, Mennes M, Marquand A, Charman T, Tillmann J, Ecker C, Dell'Acqua F, Brandeis D, Banaschewski T, Baumeister S, Moessnang C, Baron-Cohen S, Holt R, Bölte S, Durston S, Kundu P, Lombardo MV, Spooren W, Loth E, Murphy DGM, Beckmann CF, Buitelaar JK; EU-AIMS LEAP group.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Mar;4(3):260-270. doi: 10.1016/j.bpsc.2018.11.010. Epub 2018 Dec 5.

PMID:
30711508
22.

Prostate-specific Membrane Antigen Across the Spectrum of Prostate Cancer: Detection, Surgery, and Theranostics.

Murphy DG, Azad AA, Sandhu S, Violet J, Hofman MS.

Eur Urol. 2019 Jun;75(6):927-928. doi: 10.1016/j.eururo.2018.12.039. Epub 2019 Jan 5. No abstract available.

PMID:
30616952
23.

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.

Matta R, Chapple CR, Fisch M, Heidenreich A, Herschorn S, Kodama RT, Koontz BF, Murphy DG, Nguyen PL, Nam RK.

Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17. Review.

PMID:
30573316
24.

Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.

Reynolds HM, Williams S, Jackson P, Mitchell C, Hofman MS, Hicks RJ, Murphy DG, Haworth A.

BJU Int. 2019 Jun;123(6):1020-1030. doi: 10.1111/bju.14648. Epub 2019 Jan 28.

PMID:
30536698
25.

Highly Diverse Hepatitis C Strains Detected in Sub-Saharan Africa Have Unknown Susceptibility to Direct-Acting Antiviral Treatments.

Davis C, Mgomella GS, da Silva Filipe A, Frost EH, Giroux G, Hughes J, Hogan C, Kaleebu P, Asiki G, McLauchlan J, Niebel M, Ocama P, Pomila C, Pybus OG, Pépin J, Simmonds P, Singer JB, Sreenu VB, Wekesa C, Young EH, Murphy DG, Sandhu M, Thomson EC.

Hepatology. 2019 Apr;69(4):1426-1441. doi: 10.1002/hep.30342. Epub 2019 Mar 22.

26.

PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics.

Eapen RS, Nzenza TC, Murphy DG, Hofman MS, Cooperberg M, Lawrentschuk N.

World J Urol. 2019 Jul;37(7):1255-1261. doi: 10.1007/s00345-018-2524-z. Epub 2018 Oct 29.

PMID:
30374609
27.

GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models.

Horder J, Andersson M, Mendez MA, Singh N, Tangen Ä, Lundberg J, Gee A, Halldin C, Veronese M, Bölte S, Farde L, Sementa T, Cash D, Higgins K, Spain D, Turkheimer F, Mick I, Selvaraj S, Nutt DJ, Lingford-Hughes A, Howes OD, Murphy DG, Borg J.

Sci Transl Med. 2018 Oct 3;10(461). pii: eaam8434. doi: 10.1126/scitranslmed.aam8434.

28.

The Neuroanatomy of Autism Spectrum Disorder Symptomatology in 22q11.2 Deletion Syndrome.

Gudbrandsen M, Daly E, Murphy CM, Wichers RH, Stoencheva V, Perry E, Andrews D, Blackmore CE, Rogdaki M, Kushan L, Bearden CE, Murphy DGM, Craig MC, Ecker C.

Cereb Cortex. 2018 Oct 1. doi: 10.1093/cercor/bhy239. [Epub ahead of print]

PMID:
30272146
29.

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial.

Siva S, Bressel M, Murphy DG, Shaw M, Chander S, Violet J, Tai KH, Udovicich C, Lim A, Selbie L, Hofman MS, Kron T, Moon D, Goad J, Lawrentschuk N, Foroudi F.

Eur Urol. 2018 Oct;74(4):455-462. doi: 10.1016/j.eururo.2018.06.004. Epub 2018 Jun 29.

PMID:
30227924
30.

Editorial Comment.

van den Bergh RCN, van der Poel HG, Murphy DG.

J Urol. 2018 Dec;200(6):1254-1255. doi: 10.1016/j.juro.2018.06.094. Epub 2018 Sep 5. No abstract available.

PMID:
30193091
31.

Less, not More, Antibiotics Please.

Murphy DG, Alghazo O, Pascoe C, Lawrentschuk N.

Eur Urol Focus. 2018 Aug 31. pii: S2405-4569(18)30230-X. doi: 10.1016/j.euf.2018.08.011. [Epub ahead of print] No abstract available.

PMID:
30177401
32.

Current management of radiation cystitis: a review and practical guide to clinical management.

Pascoe C, Duncan C, Lamb BW, Davis NF, Lynch TH, Murphy DG, Lawrentschuk N.

BJU Int. 2019 Apr;123(4):585-594. doi: 10.1111/bju.14516. Epub 2018 Nov 28. Review.

PMID:
30113758
33.

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.

Lawrence MG, Obinata D, Sandhu S, Selth LA, Wong SQ, Porter LH, Lister N, Pook D, Pezaro CJ, Goode DL, Rebello RJ, Clark AK, Papargiris M, Van Gramberg J, Hanson AR, Banks P, Wang H, Niranjan B, Keerthikumar S, Hedwards S, Huglo A, Yang R, Henzler C, Li Y, Lopez-Campos F, Castro E, Toivanen R, Azad A, Bolton D, Goad J, Grummet J, Harewood L, Kourambas J, Lawrentschuk N, Moon D, Murphy DG, Sengupta S, Snow R, Thorne H, Mitchell C, Pedersen J, Clouston D, Norden S, Ryan A, Dehm SM, Tilley WD, Pearson RB, Hannan RD, Frydenberg M, Furic L, Taylor RA, Risbridger GP.

Eur Urol. 2018 Nov;74(5):562-572. doi: 10.1016/j.eururo.2018.06.020. Epub 2018 Jul 23.

PMID:
30049486
34.

Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update.

Wang LL, Begashaw K, Evans M, Earnest A, Evans SM, Millar JL, Murphy DG, Moon D.

ANZ J Surg. 2018 Oct;88(10):1037-1042. doi: 10.1111/ans.14722. Epub 2018 Jul 25.

PMID:
30047208
35.

Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging.

Hofman MS, Iravani A, Nzenza T, Murphy DG.

Urol Clin North Am. 2018 Aug;45(3):503-524. doi: 10.1016/j.ucl.2018.03.016. Epub 2018 Jun 15. Review.

PMID:
30031469
36.

Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.

Chiong E, Murphy DG, Akaza H, Buchan NC, Chung BH, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Ng CF, Ong T, Pu YS, Saad M, Schubach K, Türkeri L, Umbas R, Le Chuyen V, Williams S, Ye DW; ANZUP Cancer Trials Group, Davis ID.

BJU Int. 2019 Jan;123(1):22-34. doi: 10.1111/bju.14489. Epub 2018 Aug 19. Review.

PMID:
30019467
37.

Getting the Balance Right-The Benefits and Uncertainties of Focal Therapy for Significant Prostate Cancer.

Murphy DG, Tilki D.

Eur Urol. 2018 Oct;74(4):430-431. doi: 10.1016/j.eururo.2018.06.035. Epub 2018 Jul 13. No abstract available.

PMID:
30007818
38.

Sex-chromosome dosage effects on gene expression in humans.

Raznahan A, Parikshak NN, Chandran V, Blumenthal JD, Clasen LS, Alexander-Bloch AF, Zinn AR, Wangsa D, Wise J, Murphy DGM, Bolton PF, Ried T, Ross J, Giedd JN, Geschwind DH.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7398-7403. doi: 10.1073/pnas.1802889115. Epub 2018 Jun 26.

39.

PRECISION delivers on the PROMIS of mpMRI in early detection.

Nzenza T, Murphy DG.

Nat Rev Urol. 2018 Sep;15(9):529-530. doi: 10.1038/s41585-018-0046-5. No abstract available.

PMID:
29930321
40.

Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis.

Sathianathen NJ, Kuntz KM, Alarid-Escudero F, Lawrentschuk NL, Bolton DM, Murphy DG, Weight CJ, Konety BR.

J Urol. 2018 Dec;200(6):1215-1220. doi: 10.1016/j.juro.2018.06.016. Epub 2018 Jun 12.

PMID:
29906434
41.

Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast.

Bletsch A, Mann C, Andrews DS, Daly E, Tan GMY, Murphy DGM, Ecker C.

Hum Brain Mapp. 2018 Oct;39(10):4043-4054. doi: 10.1002/hbm.24230. Epub 2018 Jun 8.

PMID:
29885016
42.

Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models.

Horder J, Petrinovic MM, Mendez MA, Bruns A, Takumi T, Spooren W, Barker GJ, Künnecke B, Murphy DG.

Transl Psychiatry. 2018 May 25;8(1):106. doi: 10.1038/s41398-018-0155-1.

43.

Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria.

Evans MA, Millar JL, Earnest A, Frydenberg M, Davis ID, Murphy DG, Kearns PA, Evans SM.

Med J Aust. 2018 Jun 4;208(10):439-443. Epub 2018 May 28.

PMID:
29793403
44.

Photoselective Vaporization of the Bladder for the Management of Radiation Cystitis-Technique and Initial Outcomes.

Pascoe C, Christidis D, Manning TG, Lamb BW, Murphy DG, Lawrentschuk N.

Urology. 2019 Jan;123:295. doi: 10.1016/j.urology.2018.04.030. Epub 2018 May 16.

PMID:
29777786
45.

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.

Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Thang SP, Akhurst T, Iravani A, Kong G, Ravi Kumar A, Murphy DG, Eu P, Jackson P, Scalzo M, Williams SG, Sandhu S.

Lancet Oncol. 2018 Jun;19(6):825-833. doi: 10.1016/S1470-2045(18)30198-0. Epub 2018 May 8.

PMID:
29752180
46.

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.

Hofman MS, Murphy DG, Williams SG, Nzenza T, Herschtal A, Lourenco RA, Bailey DL, Budd R, Hicks RJ, Francis RJ, Lawrentschuk N.

BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3.

PMID:
29726071
47.

Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination.

Evans SM, Murphy DG, Davis ID, Sengupta S, Borzeshi EZ, Sampurno F, Millar JL.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e412-e419. doi: 10.1111/ajco.12875. Epub 2018 Apr 27.

PMID:
29700974
48.

Frontoparietal Tracts Linked to Lateralized Hand Preference and Manual Specialization.

Howells H, Thiebaut de Schotten M, Dell'Acqua F, Beyh A, Zappalà G, Leslie A, Simmons A, Murphy DG, Catani M.

Cereb Cortex. 2018 Jul 1;28(7):2482-2494. doi: 10.1093/cercor/bhy040.

49.

EU-AIMS Longitudinal European Autism Project (LEAP): the autism twin cohort.

Isaksson J, Tammimies K, Neufeld J, Cauvet É, Lundin K, Buitelaar JK, Loth E, Murphy DGM, Spooren W, Bölte S; EU-AIMS LEAP group.

Mol Autism. 2018 Apr 13;9:26. doi: 10.1186/s13229-018-0212-x. eCollection 2018.

50.

Balancing the benefits and harms of radiotherapy post-radical prostatectomy.

Lamb BW, Alghazo O, Murphy DG.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S128-S131. doi: 10.21037/tau.2017.10.07. No abstract available.

Supplemental Content

Loading ...
Support Center